分子影像在COVID-19中的临床应用:进展更新
本文综述了分子影像在COVID-19评估中不断演变的作用,涵盖氟-18脱氧葡萄糖(18F-FDG)PET/CT与PET/MRI对肺内外病变的评价、SPECT/CT通气灌注扫描用于血栓栓塞性疾病、COVID-19感染的长期随访及疫苗相关并发症。文章指出,随着对COVID-19多系统受累本质认识的深入,分子影像可能较标准横断面影像更早检出功能改变。
要点
- 18F-FDG PET/CT与PET/MRI可用于评估COVID-19的肺部及肺外病变。
- SPECT/CT通气灌注扫描可用于COVID-19相关血栓栓塞性疾病。
- 分子影像可能较标准横断面影像更早检出功能改变。
核心结论
- 分子影像在COVID-19肺内外病变评估、血栓栓塞性疾病、长期随访及疫苗相关并发症中具有不断演变的作用。
研究设计与样本
- 本文为综述,聚焦分子影像在COVID-19中的临床应用进展。
主要发现
- 18F-FDG PET/CT与PET/MRI可用于评估肺部及肺外COVID-19。
- SPECT/CT通气灌注扫描可用于COVID-19相关血栓栓塞性疾病。
- 分子影像可能较标准横断面影像更早检出功能改变。
关键数值与推荐
- 胸部X线与CT等常规影像可在初始诊断及部分患者随访中作为RT-PCR的补充。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The novel pathogen severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first discovered in Wuhan, China in late 2019 with Coronavirus disease 2019 (COVID-19) declared a global pandemic in March 2020. Primarily involving the lungs, conventional imaging with chest radiography and CT can play a complementary role to RT-PCR in the initial diagnosis, and also in follow up of select patients. As a broader understanding of the multi-systemic nature of COVID-19 has evolved, a potential role for molecular imaging has developed, that may detect functional changes in advance of standard cross-sectional imaging. In this review, we highlight the evolving role of molecular imaging such as fluorine-18 (18F) fluorodeoxyglucose (FDG) with PET/CT and PET/MRI in the evaluation of both pulmonary and extra-pulmonary COVID-19, ventilation and perfusion scan with SPECT/CT for thromboembolic disease, long term follow-up of COVID-19 infection, and COVID-19 vaccine-related complications.
引用
- Elsakka A, Yeh R, Das J, et al. The Clinical Utility of Molecular Imaging in COVID-19: An Update. Semin Nucl Med. 2022. PMID: 36243572. doi:10.1053/j.semnuclmed.2022.09.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。